Contract facts
NONENo full NAICS 541711 intel page yet. Browse NAICS intelligence
ADMIN ACTION TO EXTEND TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLA is a federal NONE award for Department of Defense (DOD) held by Dynport Vaccine Company LLC. Estimated value $257.4M ($-316,912.03 obligated). Current period of performance ends Mar 11, 2027. Last award drew 1 bidder. Place of performance: FREDERICK, MD. Related solicitation W911QY12R0056.
ADMIN ACTION TO EXTEND TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Recompete timing
PublicCurrent PoP ends Mar 11, 2027 (161 days remaining). Agencies typically plan 12–18 months ahead — at 5.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on W911QY13C0056? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordDynport Vaccine Company LLC — $-100,967,056 obligated across 18 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W911QY13C0056?
W911QY13C0056 (ADMIN ACTION to EXTEND termination settlement) is a W6qk Acc-Apg Natick award with an estimated value of $257.4M, currently held by Dynport Vaccine Company LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W911QY-13-C-0056?
W911QY-13-C-0056 is the dashed form of PIID W911QY13C0056 (ADMIN ACTION to EXTEND termination settlement), held by Dynport Vaccine Company LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W911QY13C0056?
W6qk Acc-Apg Natick awarded W911QY13C0056 to Dynport Vaccine Company LLC.
Who is the incumbent on W911QY13C0056?
Dynport Vaccine Company LLC is the incumbent with $-100,967,056 across 18 related awards in SCOUT’s public footprint. The current period of performance ends Mar 11, 2027.
When does Dynport Vaccine Company LLC’s W911QY13C0056 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 11, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W911QY13C0056? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.